Kumar, R., Singh, S. K., Singh, S. and Kumar , A. (2025) “Addressing cardio-metabolic risks in type 2 diabetes: evidence-based insights on efpeglenatide”, International Journal of Basic & Clinical Pharmacology, 14(4), pp. 565–582. doi: 10.18203/2319-2003.ijbcp20251843.